Method and equipment for predicting postoperative biochemical relapse of prostate cancer patient
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- WEST CHINA HOSPITAL SICHUAN UNIV
- Publication Date
- 2021-08-20
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present application relates to the technical field of prognostic evaluation of prostate cancer patients, in particular to a method and equipment for predicting postoperative biochemical recurrence of prostate cancer patients. Background technique
[0002] Surgical treatment (radical prostatectomy) is the standard of care for patients with localized prostate cancer; however, patients after radical prostatectomy may experience biochemical recurrence and subsequent disease progression. Predicting the probability of biochemical recurrence in patients can guide clinical decision-making, thereby further improving patient prognosis. Specifically, avoiding over-treatment may be considered for patients with a low predicted probability of biochemical recurrence, and more aggressive treatment should be used as much as possible for patients with a high predicted probability of biochemical recurrence to delay disease progression. In the prior art, doctors gene...